| 
|  | PJ34Chemical Information
    
        
            M.Wt
            331.8
            Storage
            Please store the product under the recom...More>> |  | 
| 
|  | UPF 1069Chemical Information
    
        
            M.Wt
            279.29
            Storage
            Please store the product under the reco...More>> |  | 
| 
|  | JW55Chemical Information
    
        
            M.Wt
            434.48
            Storage
            Please store the product under the reco...More>> |  | 
| 
|  | AZD2461Chemical Properties
    
        
            Cas No.
            1174043-16-3
            SDF
            Download SDF
        
     ...More>> |  | 
| 
|  | AG014699Description of:AG014699AG014699, the phosphate salt of AG14447, which has improved aqueous solubility, has been selected for clinical trial.AG...
 More>> |  | 
| 
|  | Veliparib(ABT888)Description of:ABT888Veliparib is a potent inhibitor of both PARP-1 and PARP-2 by [3H]NAD+ with Kis of 5.2 and 2.9 nmol/L, respectively.
 ...
 More>> |  | 
| 
|  | Iniparib(BSI-201)Description of:Iniparib(BSI-201)Iniparib(BSI-201) has first-in-class and best-in-class potential as targeted therapy for several types of canc...
 More>> |  | 
| 
|  | olaparib(AZD2281)Description of:olaparib(AZD2281)AZD2281(olaparib)shows activity in BRCA-1 deficient breast cancer cells. Cell-kill in the presence of the alky...
 More>> |  | 
| 
|  | ABT-888(Veliparib)Description of:ABT-888(Veliparib)ABT-888 is a potent inhibitor of both PARP-1 and PARP-2 by [3H]NAD+ with Kis of 5.2 and 2.9 nmol/L, respectiv...
 More>> |  | 
| 
|  | AG14361Description of:AG14361It caused a >3-fold sensitization of PARP-1+/+ cells to topotecan compared with a <1.4-fold sensitization in PARP-...
 More>> |  |